Children’s Motrin has been linked to a severe drug reaction that can cause a rare and painful skin disorder that can lead to further complications including organ damage, blindness and even death.
A Massachusetts jury awarded a $63 million verdict in the case of a girl who lost 90 percent of her skin and suffered permanent lung and liver damage and blindness after taking the ibuprofen product manufactured by a Johnson & Johnson subsidiary.
The verdict was handed down Feb. 13, 2013, more than nine years after Samantha Reckis was given the Children’s Motrin her lawsuit claimed caused toxic epidermal necrolysis, a rare and painful skin disorder, another form of the ailment known as Stevens-Johnson Syndrome.
Kline & Specter, PC, with 40 attorneys, several of whom are also highly skilled doctors, has the experience and expertise to handle pharmaceutical side effects lawsuits. The firm, based in Philadelphia, handles cases nationwide and has been a leader in medication litigation, including the $4.85 billion Vioxx settlement. At this time, however, we are no longer accepting cases involving side effects and reactions to Children's Motrin.
In the Reckis case, attorneys for the girl alleged that the label on the Children’s Motrin bottle bore only a small technical warning which failed to warn of potential adverse side effects.
Reckis was seven years old when she was given three doses of the medicine within 24 hours to treat a fever in 2003. The medicine induced toxic epidermal necrolysis, which causes the top layer of skin (epidermis) to detach from the lower layers. The rare disorder is generally caused by a severe reaction to medications and kills 40 percent of those who contract it.
Reckis is now 16. She has had to undergo 40 surgeries, including six brain operations, and has suffered an aneurysm and stroke. Her lungs function at only 20 percent and she cannot walk more than 150 yards without becoming exhausted, according to an article in The Boston Globe.